Organon Affirms FY2025 Sales Guidance of $6.13B-$6.33B vs $6.23B Est

Author: Benzinga Newsdesk | May 01, 2025 07:21am

Full year 2025 financial guidance is presented below on a non-GAAP basis, except revenue.

		Previous Guidance as of February 13, 2025		Current Guidance
Revenue		$6.125B-$6.325B		Unchanged
FX translation headwind		~$200M		Unchanged, but with potential upside at current rates
Adjusted gross margin		60.0%-61.0%		Unchanged
SG&A		Mid 20% range		Unchanged
R&D		Upper single-digit		Unchanged
IPR&D*		-		$6 million
Adjusted EBITDA margin (Non-GAAP)		31.0%-32.0%		Unchanged
Interest		~$510M		Unchanged
Depreciation		~$135M		Unchanged
Effective non-GAAP tax rate		22.5%-24.5%		Unchanged
Fully diluted weighted average shares outstanding		~263M		Unchanged

Posted In: OGN